Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.
2.

Psychosocial stress and cardiovascular disease Part 2: effectiveness of the Transcendental Meditation program in treatment and prevention.

Walton KG, Schneider RH, Nidich SI, Salerno JW, Nordstrom CK, Bairey Merz CN.

Behav Med. 2002 Fall;28(3):106-23. Review.

3.
4.

Stress reduction in the secondary prevention of cardiovascular disease: randomized, controlled trial of transcendental meditation and health education in Blacks.

Schneider RH, Grim CE, Rainforth MV, Kotchen T, Nidich SI, Gaylord-King C, Salerno JW, Kotchen JM, Alexander CN.

Circ Cardiovasc Qual Outcomes. 2012 Nov;5(6):750-8. doi: 10.1161/CIRCOUTCOMES.112.967406. Epub 2012 Nov 13.

6.

Long-term effects of stress reduction on mortality in persons > or = 55 years of age with systemic hypertension.

Schneider RH, Alexander CN, Staggers F, Rainforth M, Salerno JW, Hartz A, Arndt S, Barnes VA, Nidich SI.

Am J Cardiol. 2005 May 1;95(9):1060-4.

7.

Lowering cortisol and CVD risk in postmenopausal women: a pilot study using the Transcendental Meditation program.

Walton KG, Fields JZ, Levitsky DK, Harris DA, Pugh ND, Schneider RH.

Ann N Y Acad Sci. 2004 Dec;1032:211-5.

PMID:
15677413
8.
9.

Meditation can produce beneficial effects to prevent cardiovascular disease.

Koike MK, Cardoso R.

Horm Mol Biol Clin Investig. 2014 Jun;18(3):137-43. doi: 10.1515/hmbci-2013-0056. Review.

PMID:
25390009
10.

A controlled study of the effects of the Transcendental Meditation program on cardiovascular reactivity and ambulatory blood pressure.

Wenneberg SR, Schneider RH, Walton KG, Maclean CR, Levitsky DK, Salerno JW, Wallace RK, Mandarino JV, Rainforth MV, Waziri R.

Int J Neurosci. 1997 Jan;89(1-2):15-28.

PMID:
9134445
11.

Yoga and meditation in cardiovascular disease.

Manchanda SC, Madan K.

Clin Res Cardiol. 2014 Sep;103(9):675-80. doi: 10.1007/s00392-014-0663-9. Epub 2014 Jan 25. Review. Erratum in: Clin Res Cardiol. 2014 Sep;103(9):763.

PMID:
24464106
12.

Trial of stress reduction for hypertension in older African Americans. II. Sex and risk subgroup analysis.

Alexander CN, Schneider RH, Staggers F, Sheppard W, Clayborne BM, Rainforth M, Salerno J, Kondwani K, Smith S, Walton KG, Egan B.

Hypertension. 1996 Aug;28(2):228-37.

13.

Stress reduction programs in patients with elevated blood pressure: a systematic review and meta-analysis.

Rainforth MV, Schneider RH, Nidich SI, Gaylord-King C, Salerno JW, Anderson JW.

Curr Hypertens Rep. 2007 Dec;9(6):520-8. Review.

15.

Blood pressure response to transcendental meditation: a meta-analysis.

Anderson JW, Liu C, Kryscio RJ.

Am J Hypertens. 2008 Mar;21(3):310-6. doi: 10.1038/ajh.2007.65. Epub 2008 Jan 31.

PMID:
18311126
16.

Lower lipid peroxide levels in practitioners of the Transcendental Meditation program.

Schneider RH, Nidich SI, Salerno JW, Sharma HM, Robinson CE, Nidich RJ, Alexander CN.

Psychosom Med. 1998 Jan-Feb;60(1):38-41.

PMID:
9492237
17.

Transcendental meditation, hypertension and heart disease.

King MS, Carr T, D'Cruz C.

Aust Fam Physician. 2002 Feb;31(2):164-8. Review.

PMID:
11917830
19.

Effects of stress reduction on carotid atherosclerosis in hypertensive African Americans.

Castillo-Richmond A, Schneider RH, Alexander CN, Cook R, Myers H, Nidich S, Haney C, Rainforth M, Salerno J.

Stroke. 2000 Mar;31(3):568-73.

20.

Design and rationale of a comparative effectiveness trial evaluating transcendental meditation against established therapies for PTSD.

Rutledge T, Nidich S, Schneider RH, Mills PJ, Salerno J, Heppner P, Gomez MA, Gaylord-King C, Rainforth M.

Contemp Clin Trials. 2014 Sep;39(1):50-6. doi: 10.1016/j.cct.2014.07.005. Epub 2014 Jul 25.

PMID:
25066921

Supplemental Content

Support Center